Inari Medical, Inc. (NARI)

Inari Medical Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Net Income	-23.62	-1.64	-29.27	9.84	13.79	-1.19
Depreciation & Amortization	12.38	10.74	7.12	4.31	1.39	0.61
Share-Based Compensation	42.87	40.34	28.67	25.45	3.52	0.51
Other Operating Activities	-5.97	-13.51	-20.5	-14.11	-16.79	-4.86
Operating Cash Flow	25.65	35.93	-13.97	25.49	1.91	-4.94
Operating Cash Flow Growth	-	-	-	1232.95%	-	-
Capital Expenditures	-7.15	-6.2	-9.95	-13.65	-5.46	-3.14
Acquisitions	-240.42	-240.42	0	0	0	0
Change in Investments	232.75	188.6	-185.27	-37.38	-49.98	0
Investing Cash Flow	-14.81	-58.02	-195.22	-51.02	-55.44	-3.14
Share Issuance / Repurchase	10.48	10.75	183.63	6.43	164.83	0.9
Debt Issued / Paid	0	0	0	0	-20.25	9.86
Other Financing Activities	-10.76	-9.57	-6.49	-2.35	-0.47	-0.54
Financing Cash Flow	-0.28	1.17	177.14	4.07	144.12	10.22
Exchange Rate Effect	0.09	-0.09	-0.48	-0.4	0	0
Net Cash Flow	10.65	-21.01	-32.53	-21.87	90.59	2.14
Free Cash Flow	18.51	29.73	-23.92	11.84	-3.55	-8.08
Free Cash Flow Margin	3.55%	6.02%	-6.24%	4.27%	-2.54%	-15.80%
Free Cash Flow Per Share	0.32	0.52	-0.45	0.24	-0.11	-1.37

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).